IRIS
CIANCIARUSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.077
AS - Asia 2.731
EU - Europa 1.835
SA - Sud America 402
AF - Africa 69
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.118
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.970
SG - Singapore 1.307
RU - Federazione Russa 872
CN - Cina 499
VN - Vietnam 432
BR - Brasile 331
HK - Hong Kong 238
UA - Ucraina 191
IT - Italia 169
DE - Germania 144
FI - Finlandia 110
FR - Francia 97
GB - Regno Unito 62
IE - Irlanda 59
CA - Canada 53
IN - India 53
SE - Svezia 48
MX - Messico 33
AR - Argentina 32
JP - Giappone 32
ZA - Sudafrica 25
IQ - Iraq 23
BD - Bangladesh 22
PL - Polonia 19
NL - Olanda 15
PH - Filippine 13
TR - Turchia 13
TH - Thailandia 12
ES - Italia 11
EC - Ecuador 10
JO - Giordania 9
CI - Costa d'Avorio 8
KR - Corea 8
PK - Pakistan 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
IR - Iran 7
MA - Marocco 7
TW - Taiwan 7
EG - Egitto 6
LT - Lituania 6
ID - Indonesia 5
UZ - Uzbekistan 5
AT - Austria 4
CL - Cile 4
GR - Grecia 4
KE - Kenya 4
PY - Paraguay 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
BB - Barbados 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GH - Ghana 3
JM - Giamaica 3
MY - Malesia 3
OM - Oman 3
TN - Tunisia 3
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MZ - Mozambico 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NA - Namibia 1
NE - Niger 1
NP - Nepal 1
Totale 8.106
Salva come PNG Salva come JPEG
Città #
Singapore 604
San Jose 471
Chandler 238
Hong Kong 234
Jacksonville 213
Moscow 210
Santa Clara 188
Ashburn 185
Beijing 143
Ho Chi Minh City 125
The Dalles 110
Hanoi 88
Los Angeles 87
Princeton 86
Boston 73
Lauterbourg 72
Millbury 66
Wilmington 58
Nanjing 54
New York 45
Buffalo 40
São Paulo 35
Nanchang 30
Haiphong 27
Munich 27
Tokyo 26
Council Bluffs 23
Da Nang 23
Ottawa 23
Chennai 21
Dallas 21
Seattle 20
Napoli 19
Phoenix 18
Warsaw 18
Helsinki 17
Ann Arbor 16
Rio de Janeiro 16
Montreal 15
Naples 15
Baghdad 14
Mexico City 14
Norwalk 14
Orem 14
Stockholm 14
Atlanta 13
Brooklyn 13
Redondo Beach 13
Boardman 12
San Francisco 12
Amsterdam 11
Shenyang 11
Falls Church 10
Hefei 10
Houston 10
Poplar 10
Chicago 9
Denver 9
Frankfurt am Main 9
Kunming 9
Orange 9
Rome 9
Amman 8
Changsha 8
Hebei 8
Johannesburg 8
Milan 8
Tianjin 8
Turku 8
Falkenstein 7
Kronberg 7
Nuremberg 7
Secaucus 7
Augusta 6
Biên Hòa 6
Guarulhos 6
Toronto 6
Brasília 5
Bình Dương 5
Caracas 5
Des Moines 5
Guangzhou 5
Hangzhou 5
Hải Dương 5
London 5
Manaus 5
Mumbai 5
New Delhi 5
Ninh Bình 5
Philadelphia 5
Piracicaba 5
Pune 5
Tashkent 5
Thái Nguyên 5
Bangkok 4
Cairo 4
Campinas 4
Can Tho 4
Colombo 4
Curitiba 4
Totale 4.266
Salva come PNG Salva come JPEG
Nome #
Endocrine dysfunction in patients with Fabry disease 193
Body composition and cardiovascular risk factors in pretransplant hemodialysis patients 159
Preclinical Systolic Dysfunction In Patients With Stage 3 Chronic Renal Disease 155
Atorvastatin improves the course of ischemic acute renal failure in aging rats 146
Early Changes in Bioelectrical Estimates of Body Composition in Chronic Kidney Disease 133
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency 133
PREVALENCE OF CORONARY ARTERY CALCIFICATION IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY NOT UNDERGOING DIALYSIS 133
Thyroid function in Fabry disease before and after enzyme replacement therapy. 130
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 129
Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. 127
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 125
Cardiac performance during exercise in patients with Fabry's disease 125
Insomnia in maintenance haemodialysis patients. 123
Relationship between serum albumin concentration and tubular reabsorption of glucose in renal disease. 123
Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients 121
Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease 121
Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. 121
Short-term effects of low protein-normal sodium diet on renal function in chronic renal failure 120
Stability of target hemoglobin levels during the first year of epoetin treatment in patients with chronic kidney disease. 119
Preclinical systolic dysfunction in patients with stage 3 chronic kidney disease 118
Visceral Leishmaniasis in renal transplant recipients. Is it still a challange to the Nephrologist? 117
Treatment of arterial hypertension with minoxidil in renal insufficiency 117
Effects of atorvastatin on renal function in patients with chronic renal failure. 114
Body weight is a fluctuating parameter in hemodialysis patients 111
Arginase inhibition slows the progression of renal failure in rats with renal ablation 111
Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. 109
Zaleplon improves sleep quality in maintenance hemodialysis patients. 109
sleep quality in renal transplant patients: a never investigated problem. 108
Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. 108
Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease 106
Randomized,double-blind,placebo-controlled study of arginine supplementation in chronic renal failure 106
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease 106
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 105
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 105
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. 104
Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement. 104
Renal transplantation and sleep: a new life is not enough 104
Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact. 97
Zaleplon improves sleep quality in maintenance hemodialysis patients 96
Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients 96
The impact of haemoglobin on the quality of sleep in haemodialysis patients: which is the truth? 96
Assessment of Nutritional Practice in Italian Chronic Kidney Disease Clinics: A Questionnaire-Based Survey 96
[Fabry nephropathy in a female with superposed IgA glomerulonephritis]. 96
Salt intake and renal outcome in patients with progressive renal disease 95
Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease 94
Hepatitis C and kidney disease. 93
Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire-based survey. 93
Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients 92
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. 92
Effects of atorvastatin on renal function in patients with chronic renal failure. PMID: 90
Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure 90
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients 86
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis. 85
EFFECT OF MAINTENANCE TREATMENT WITH MYCOPHENOLATE MOFETIL ON CHRONIC INFLAMMATORY STATUS IN PROLIFERATIVE LUPUS NEPHRITIS 84
Some sodium, potassium and water changes in the elderly and their treatment 81
Enhancement of nitric oxide synthesis by L-Arginine supplementation in renal disease: Is it good or bad? 79
Effects of age on hypertensive status in patients with chronic kidney disease. 79
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study 78
Assessment of nutritional practice in Italian chronic kidney disease clinics: a questionnaire-based survey. 78
Renal handling of urea in subjects with persistent azotemia and normal renal function 76
Visceral Leishmaniasis in renal transplant recipients. It is still a challenge to the nephrologist? 75
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 75
Is Bioimpedance Analysis a Useful Tool To Predict Resting Energy Expenditure in Haemodialysis Patients? 74
NET RELEASE OR UPTAKE OF HISTIDINE AND CARNOSINE IN KIDNEY OF DOGS 74
HEPATIC UPTAKE AND RELEASE OF GLUCOSE,LACTATE. AND AMINO ACIDS IN ACUTELY UREMIC DOGS 74
Italian randomized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease. 74
Fabry Registry. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. 73
Expert working group report on nutrition in adult patients with renal insufficiency. 70
INSOMNIA IN MAINTENANCE HAEMODYALISIS PATIENTS 68
The impact of haemoglobin on the quality of sleep in heamodialysis patients: which is the truth? 68
NATURAL COURSE OFANEMIA IN A LARGE POPULATION OF PATIENTS WITH INITIAL TO ADVANCED CHRONIC RENAL FAILURE 67
LINEE GUIDA PER IL TRATTAMENTO DELL'ANEMIA NELL'INSUFFICIENZA RENALE 65
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry. 65
Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure 64
MRI characterization of myocardial tissue in patients with Fabry's disease 61
Detection and Awareness of Moderate to Advanced CKD by Primary Care Practitioners: A Cross-sectional Study From Italy. 61
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry. 61
Prognosis of CKD patients receiving outpatient nephrology care in Italy. 61
Nutritional status in the elderly patient with uraemia 60
Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. 60
Expert working group report on nutrition in adult patients with renal insufficiency. 59
The impact of early normalization of hematocrit by erythropoietin on renal damage in remnant rats. 58
Expert working group report on nutrition in adult patients with renal insufficiency. 57
Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy 56
Fabry disease: perspectives of urinary proteomics. 56
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. 55
Totale 8.231
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022465 3 0 0 2 5 15 1 16 66 68 108 181
2022/2023478 100 50 4 54 56 51 0 45 77 9 26 6
2023/2024294 13 64 31 12 12 15 4 29 1 9 76 28
2024/20252.166 128 187 12 13 30 205 278 94 145 197 718 159
2025/20263.786 436 213 350 413 731 187 535 197 342 212 89 81
2026/202765 65 0 0 0 0 0 0 0 0 0 0 0
Totale 8.231